Literature DB >> 1821364

Current assessment practices for noncancer end points.

C R Shoaf1.   

Abstract

The need for assessing noncancer risks for agents to which humans are routinely exposed indoors arises from the large amount of time spent indoors (i.e., employed persons spend about 60% of their time at home indoors, 30% at work indoors, and 5% in transit). Sources of air pollutants include heating and cooling systems, combustion appliances, personal use products, furnishings, tobacco products, pesticides, bioeffluents from humans and animals, and other microbial contamination such as toxins from molds. The purpose of this paper is to describe current dose-response assessment methods applicable to assessing risk following exposure to indoor air pollutants. The role of structure-activity relationships in hazard identification is also described. Risk assessments from exposure to indoor air pollutants require exposure assessments and dose-response assessments. Dose-response assessment methodologies include the inhalation reference concentration (RfC), structure-activity relationships, dose-response models, and the decision analytic approach. The RfC is an estimate (with uncertainty spanning perhaps an order of magnitude) of a daily exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime. The current RfC method provides guidelines for making the necessary dosimetric adjustments for gases and aerosols. Human equivalent concentrations for no-observed-adverse-effect levels in animals are determined by using mathematical relationships that adjust for regional deposition, solubility, ventilation rate, and blood:air partition coefficients. The RfC methodology exists as an interim methodology. Future scientific advancements are expected to further refine the approach.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821364      PMCID: PMC1568395          DOI: 10.1289/ehp.9195111

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  8 in total

1.  Estimating equivalent human concentrations of no observed adverse effect levels: a comparison of several methods.

Authors:  J H Overton; A M Jarabek
Journal:  Exp Pathol       Date:  1989

2.  A risk assessment for selected lead-induced health effects: an example of a general methodology.

Authors:  R G Whitfield; T S Wallsten
Journal:  Risk Anal       Date:  1989-06       Impact factor: 4.000

3.  Novel methods for the estimation of acceptable daily intake.

Authors:  M L Dourson; R C Hertzberg; R Hartung; K Blackburn
Journal:  Toxicol Ind Health       Date:  1985-12       Impact factor: 2.273

4.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

Authors:  J C Ramsey; M E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  1984-03-30       Impact factor: 4.219

5.  A new method for determining allowable daily intakes.

Authors:  K S Crump
Journal:  Fundam Appl Toxicol       Date:  1984-10

6.  Deposition and retention models for internal dosimetry of the human respiratory tract. Task group on lung dynamics.

Authors:  D V Bates; B R Fish; T F Hatch; T T Mercer; P E Morrow
Journal:  Health Phys       Date:  1966-02       Impact factor: 1.316

7.  Fitting the rectangular hyperbola.

Authors:  C I Bliss; A T James
Journal:  Biometrics       Date:  1966-09       Impact factor: 2.571

8.  Inhalation reference dose (RfDi): an application of interspecies dosimetry modeling for risk assessment of insoluble particles.

Authors:  A M Jarabek; M G Menache; J H Overton; M L Dourson; F J Miller
Journal:  Health Phys       Date:  1989       Impact factor: 1.316

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.